Prior Positive Results Confirmed in MAPS-Sponsored, Philanthropy-Funded Phase 3 Trial
The world's most advanced psychedelic-assisted therapy trial has confirmed positive findings in the second Phase 3 trial of MDMA-assisted therapy for PTSD.
MDMA
Second MAPS-Sponsored Phase 3 Trial of MDMA-Assisted Therapy for PTSD Completed (MAPP2)
MAPS Public Benefit Corporation (MAPS PBC) has announced that the final participant in the second Phase 3 trial of psychedelic-assisted therapy, A Multi-Site Phase 3 Study of MDMA-Assisted Therapy for …
Second MAPS-Sponsored Phase 3 Trial of MDMA-Assisted Therapy for PTSD Completed
FOR IMMEDIATE RELEASE: November 17, 2022 MAPS Public Benefit Corporation (MAPS PBC) has announced that the final participant in the second Phase 3 trial of psychedelic-assisted therapy, A Multi-Site Phase …
MDMA Therapy Training Program Update: October 2022
In September, the Training Team delivered two trainings for clinicians and behavioral health practitioners in MDMA-assisted therapy. One training was delivered September 12-18 at Stony Point Center in …
Now Enrolling: Long-Term Follow Up Study MPLONG
Enrollment continues in MPLONG, a long-term follow-up observational study for participants in MAPS-sponsored Phase 3 studies of MDMA-assisted therapy for the treatment of PTSD. You are eligible to participate …
Currently Enrolling: Food Effect on Bioavailability of MDMA in Healthy Volunteers Study (MPKF)
In August 2022, the first participant was enrolled and received the study drug in our Phase 1 food effect study. This study is examining the effect of food on the bioavailability of MDMA in healthy volunteers …
MDMA Therapy Training Program Update: August 2022
In July 2022, the MDMA Therapy Training team delivered training for Naropa University’s inaugural psychedelic-assisted therapies certificate cohort. The training retreat was hosted at Drala Mountain …
Five Participants Enrolled in Phase 2 Study at the Bronx, New York Veterans Affairs Medical Center
As of August 8, 2022, a total of five participants have been enrolled and the Bronx VA site continues to actively screen for new participants. Enrollment is continuing for this Phase 2, open-label study …
Food Effect on Bioavailability of MDMA in Healthy Volunteers Study (MPKF) Open for Enrollment
On July 28, 2022, the first participant was screened for the Phase 1 food effects study. This study is enrolling healthy volunteers and examines the effect of food on the bioavailability of MDMA. The …
MDMA Therapy Training Program Update: July 2022
In June 2022, the MDMA Therapy Training Team delivered two more trainings, including a week-long in-person training retreat in New York and a week-long training in California in collaboration with the …
MDMA and Healing a Dis-regulated Nervous System
“I have worked with a lot of medicine on my healing journey. Dozens of ayahuasca ceremonies. Extensive experience with psilocybin, ketamine, kambo, and deep sessions with 5-MeO. While I’ve had …
First Participant Completes Treatment in Phase 2 Study at the Bronx, New York Veterans Affairs Medical Center
Enrollment is continuing for our Phase 2, open-label study on the effectiveness of MDMA-assisted therapy in U.S. Veterans with chronic PTSD. This study is a comparative study that assesses two versus three …